|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.19 USD | +1.33% |
|
+1.12% | +15.37% |
Elanco Animal Health Incorporated updated earnings guidance for the full year 2024. For the year, company expects revenue to be in range of $4,460 Million to $4,515 Million against previous guidance of $4,450 Million to $4,540 Million. Reported Net Loss of $45 Million to $3 Million against previous guidance of $62 to $17 million.
Reported Loss per share of $0.09 to $0.01 against previous guidance of $0.12 to $0.03.
| 1st Jan change | Capi. | |
|---|---|---|
| +15.37% | 8.49B | |
| -11.83% | 79.42B | |
| +28.00% | 3.8B | |
| -1.81% | 3.23B | |
| +19.93% | 1.75B | |
| -3.25% | 1.61B | |
| -18.63% | 1.36B | |
| -0.98% | 1.3B | |
| -6.77% | 1.22B | |
| +2.34% | 1.11B |
ELANCO ANIMAL HEALTH INCORPORATED 
